Functional analysis of 5-lipoxygenase promoter repeat variants

Human Molecular Genetics

Volumn 18, Issue 23, 2009, Pages 4521-4529

  Vikman, Susanna ^a   Brena, Romulo M ^a   Armstrong, Patrice ^b   Hartiala, Jaana ^a   Stephensen, Charles B ^b   Allayee, Hooman ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; DNA; LEUKOTRIENE A4 HYDROLASE;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL POPULATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GRANULOCYTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; INTRON; LEUKOCYTE; LYMPHOCYTE; MALE; METHYLATION; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; WILD TYPE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ARACHIDONATE 5-LIPOXYGENASE; CARRIER PROTEINS; CELLS, CULTURED; CPG ISLANDS; DNA METHYLATION; EPOXIDE HYDROLASES; FEMALE; GENE EXPRESSION; GENETIC VARIATION; HUMANS; LEUKOCYTES; MALE; MEMBRANE PROTEINS; MICROSATELLITE REPEATS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 70449386908     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp414     Document Type: Article

References (36)

1. Mehrabian, M. and Allayee, H. (2003) 5 -Lipoxygenase and atherosclerosis. Curr. Opin. Lipidol., 14, 447-457.
2. T ymchuk, C.N., Hartiala, J., Patel, P.I., Mehrabian, M. and Allayee, H. (2006) Nonconventional genetic risk factors for cardiovascular disease. Curr. Atheroscler. Rep., 8, 184-192.
3. Back, M. and Hansson, G.K. (2006) Leukotriene receptors in atherosclerosis. Ann. Med., 38, 493-502.
4. Helgadottir, A., Manolescu, A., Thorleifsson, G., Gretarsdottir, S., Jonsdottir, H., Thorsteinsdottir, U., Samani, N.J., Gudmundsson, G., Grant, S.F., Thorgeirsson, G. et al. (2004) The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet., 36, 233-239.
5. Helgadottir, A., Gretarsdottir, S., St Clair, D., Manolescu, A., Cheung, J., Thorleifsson, G., Pasdar, A., Grant, S.F., Whalley, L.J., Hakonarson, H. et al. (2005) Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am. J. Hum. Genet., 76, 505-509.
6. Zee, R.Y., Cheng, S., Hegener, H.H., Erlich, H.A. and Ridker, P.M. (2006) Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach. Stroke, 37, 2007-2011.
7. Koch, W., Hoppmann, P., Mueller, J.C., Schomig, A. and Kastrati, A. (2007) No association of polymorphisms in the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a large central European population. Genet. Med., 9, 123-129.
8. Zintzaras, E., Rodopoulou, P. and Sakellaridis, N. (2009) Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: A HuGE gene-disease association review and meta-analysis. Am. J. Epidemiol., 169, 523-532.
9. Helgadottir, A., Manolescu, A., Helgason, A., Thorleifsson, G., Thorsteinsdottir, U., Gudbjartsson, D.F., Gretarsdottir, S., Magnusson, K.P., Gudmundsson, G., Hicks, A. et al. (2006) A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat. Genet., 38, 68-74.
10. Iovannisci, D.M., Lammer, E.J., Steiner, L., Cheng, S., Mahoney, L.T., Davis, P.H., Lauer, R.M. and Burns, T.L. (2007) Association between a leukotriene C4 synthase gene promoter polymo rphism and coronary artery calcium in young women: The Muscatine Study. Arterioscler. Thromb. Vasc. Biol., 27, 394-399.
11. Dwyer, J.H., Allayee, H., Dwyer, K.M., Fan, J., Wu, H., Mar, R., Lusis, A.J. and Mehrabian, M. (2004) Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N. Engl. J. Med., 350, 29-37.
12. Allayee, H., Baylin, A., Hartiala, J., Wijesuriya, H., Mehrabian, M., Lusis, A.J. and Campos, H. (2008) Nutrigenetic association of the 5-lipoxygenase gene with myocardial infarction. Am. J. Clin. Nutr. 88, 934-940.
13. Crosslin, D.R., Shah, S.H., Nelson, S.C., Haynes, C.S., Connelly, J.J., Gadson, S., Goldschmidt-Clermont, P.J., Vance, J.M., Rose, J., Granger, C.B. et al. (2009) Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis. Hum. Genet., 125 217-229.
14. In, K.H., Asano, K., Beier, D., Grobholz, J., Finn, P.W., Silverman, E.K., Silverman, E.S., Collins, T., Fischer, A.R., Keith, T.P. et al. (1997) Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J. Clin. Invest., 99, 1130-1137.
15. In, K.H., Silverman, E.S., Asano, K., Beier, D., Fischer, A.R., Keith, T.P., Serino, K., Yandava, C., De Sanctis, G.T. and Drazen, J.M. (1999) Mutations in the human 5-lipoxygenase gene. Clin. Rev. Allergy Immunol., 17, 59-69.
16. Drazen, J.M., Yandava, C.N., Dube, L., Szczerback, N., Hippensteel, R., Pillari, A., Israel, E., Schork, N., Silverman, E.S., Katz, D.A. et al. (1999) Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat. Genet., 22, 168-170.
17. Silverman, E.S. and Drazen, J.M. (1999) The biology of 5-lipoxygenase: function, structure, and regulatory mechanisms. Proc. Assoc. Am. Physicians, 111, 525-536.
18. Kim, S.H., Bae, J.S., Suh, C.H., Nahm, D.H., Holloway, J.W. and Park, H.S. (2005) Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: A positive association with airway hyperresponsiveness. Allergy, 60, 760-765.
19. Lima, J.J., Zhang, S., Grant, A., Shao, L., Tantisira, K.G., Allayee, H., Wang, J., Sylvester, J., Holbrook, J., Wise, R. et al. (2006) Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am. J. Respir. Crit. Care Med., 173, 379-385.
20. Radmark, O., Werz, O., Steinhilber, D. and Samuelsson, B. (2007) 5-Lipoxygenase: Regulation of expression and enzyme activity. Trends Biochem. Sci., 32, 332-341.
21. Hansson, G.K., Robertson, A.K. and Soderberg-Naucler, C. (2006) Inflammation and atherosclerosis. Annu. Rev. Pathol., 1, 297-329.
22. DiMeo, D., Tian, J., Zhang, J., Narushima, S. and Berg, D.J. (2008) Increased interleukin-10 production and Th2 skewing in the absence of 5-lipoxygenase. Immunology, 123, 250-262.
23. Hansson, G.K. (2005) Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med., 352, 1685-1695.
24. Cook-Moreau, J.M., El-Makhour Hojeij, Y., Barriere, G., Rabinovitch-Chable, H.C., Faucher, K.S., Sturtz, F.G. and Rigaud, M.A. (2007) Expression of 5-lipoxygenase (5-LOX) in T lymphocytes. Immunology, 122, 157-166.
25. Spanbroek, R., Grabner, R., Lotzer, K., Hildner, M., Urbach, A., Ruhling, K., Moos, M.P., Kaiser, B., Cohnert, T.U., Wahlers, T. et al. (2003) Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc. Natl Acad. Sci. USA, 100, 1238-1243.
26. Harle, D., Radmark, O., Samuelsson, B. and Steinhilber, D. (1999) Transcriptional and posttranscriptional regulation of 5-lipoxygenase mRNA expression in the human monocytic cell line Mono Mac 6 by transforming growth factor-beta and 1,25-dihydroxyvitamin D3. Adv. Exp. Med. Biol., 469, 105-111.
27. Seuter, S., Vaisanen, S., Radmark, O., Carlberg, C. and Steinhilber, D. (2007) Functional characterization of vitamin D responding regions in the human 5-lipoxygenase gene. Biochim. Biophys. Acta, 1771, 864-872.
28. Uhl, J., Klan, N., Rose, M., Entian, K.D., Werz, O. and Steinhilber, D. (2002) The 5-lipoxygenase promoter is regulated by DNA methylation. J. Biol. Chem., 277, 4374-4379.
29. Lee, J.H., O'Keefe, J.H., Bell, D., Hensrud, D.D. and Holick, M.F. (2008) Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J. Am. Coll. Cardiol., 52, 1949-1956.
30. Gonzalez, P., Reguero, J.R., Lozano, I., Moris, C. and Coto, E. (2007) A functional Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene is not associated with myocardial infarction. Int. J. Immunogenet., 34, 127-130.
31. Pike, B.L., Greiner, T.C., Wang, X., Weisenburger, D.D., Hsu, Y.H., Renaud, G., Wolfsberg, T.G., Kim, M., Weisenberger, D.J., Siegmund, K.D. et al. (2008) DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia 22, 1035-1043.
32. Killian, J.K., Bilke, S., Davis, S., Walker, R.L., Killian, M.S., Jaeger, E.B., Chen, Y., Hipp, J., Pittaluga, S., Raffeld, M. et al. (2009) Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. Cancer Res., 69, 758-764.
33. Radmark, O. (2002) Arachidonate 5-lipoxygenase. Prostaglandins Other Lipid Mediat., 68-69, 211-234.
34. Ehrich, M., Nelson, M.R., Stanssens, P., Zabeau, M., Liloglou, T., Xinarianos, G., Cantor, C.R., Field, J.K. and van den Boom, D. (2005) Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl Acad. Sci. USA, 102, 15785-15790.
35. Coolen, M.W., Statham, A.L., Gardiner-Garden, M. and Clark, S.J. (2007) Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: Critical evaluation and improvements. Nucleic Acids Res., 35, e119.
36. Clark, S.J., Harrison, J., Paul, C.L. and Frommer, M. (1994) High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22, 2990-2997.